Get started
RocketTickers

Vanda Announces Positive Phase II Study Results for Tradipitant

Long
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)  
RocketTickers  
NASDAQ:VNDA   Vanda Pharmaceuticals Inc.
Beyond Technical Analysis
1
0
beyondta
VNDA: Vanda Pharmaceuticals Inc.
2018-12-03 06:00:00
Vanda Announces Positive Phase II Study Results for Tradipitant in Patients with Gastroparesis
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.